Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GloMY
ISRCTN11937028Phase 3Terminated
- Sponsor
- University Hospitals Birmingham
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised, open-label trial of mycophenolate sodium and prednisolone in focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) (3 arms), sponsored by University Hospitals Birmingham. Started Oct 2010; status: terminated.
02
Drugs
mycophenolate sodiumprednisolone
03
Conditions
focal segmental glomerulosclerosis (FSGS)IgA nephropathy (IgAN)
Beyond the preview
Go deeper on ISRCTN11937028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11937028.